Przemyslaw(Mike) Sapieha, Ph.D Founder & Chief Scientific Officer
Director of the Neurovascular Eye Disease Lab at Maisonneuve-Rosemont Hospital Research Centre and Wolfe Professor of translational vision research, Canada Research Chair in retinal cell biology.
Mike (Przemyslaw) Sapieha is the Founder and Chief Scientific Officer of SemaThera.
In addition, he is the Wolfe Professor of translational vision research and Canada Research Chair in retinal cell biology at the Maisonneuve-Rosemont Hospital Research Centre of the University of Montreal. He obtained his PhD in cell biology from University of Montreal and pursued postdoctoral fellowships at McGill and Harvard. His team made significant discoveries implicating deregulation of neuronal metabolism and cellular senescence in retinal vascular diseases such as diabetic retinopathy. Notably, they identified roles for guidance cues such as Semaphorins and Netrins in these diseases.